Cogent Biosciences
cogentbio.com
Actively hiring
Health Care
Biotechnology
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Hiring now
7
+3 posted in 30 days
Backers
2
Atlas Venture, New Leaf Venture Partners
Momentum
17/100
hiring for its size
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Atlas Venture 
New Leaf Venture Partners Similar startupsby what they do, their industry and backers
DEVELOPING INHALED THERAPEUTICS IN RESPIRATORY DISEASES. Kinaset is developing KN-002 to treat all patients with severe asthma regardless…
Kailera is a late clinical-stage biotechnology company advancing a diversified pipeline of GLP-1 therapies to provide options for people…
Matchpoint aims to discover and develop precision small molecules that harness the power of covalency to bring new possibilities to the…
AAVantgarde is a clinical-stage biotechnology company developing next-generation therapies for inherited retinal diseases with high unmet…
Synlogic is the leading company advancing therapeutics based on synthetic biology, working at the intersection of biology and engineering…
Pulmocide is a biotechnology company developing novel inhaled medicines for pulmonary aspergillosis and other hard-to-treat respiratory…
Overview
Cogent Biosciences is a biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent's lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling.
News
Unum Therapeutics Announces Company Name Change to Cogent Biosciences, Highlights Recent Scientific and Operational Progress
/PRNewswire/ -- Unum Therapeutics Inc. ("Unum") (NASDAQ: UMRX), a biotechnology company focused on developing precision therapies for genetically defined...
Read more
Report
Tech stack
Technologies named in job postings at Cogent Biosciences over the last 12 months, by layer, with the share of postings for each.
Technologies in use
6
Postings analysed
3
Stack modernity
46/100
Cloud & platforms
Linux
Unix
Developer tools
SLURM
CAPA
Practices & domains
HPC
Mixture of Experts
Sign in to see how your skills match this stack
Sign In
Growth
Hiring Momentum
28/100
Slowing
Open positions
7
0 opened / 0 closed in 30 days
ATS activity
Every ~11 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Legal
40% ▲
Science & Research
40% ▼
Finance
20% ▲
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
2
Countries
1
Busiest office
Boulder
Loading the map
Headquarters
Builds here
Office with open vacancies
Tap a pin for the office
Boulder
United States
Engineering / R&D
Boulder, Colorado
3 open roles 1 posted in 90 days 100% engineering
hires for Science & Research
Waltham
United States
Regional office
The patient must reside in the United States.
2 open roles 2 posted in 90 days 50% remote
hires for Finance, Legal
180 Third Avenue, 4th floor, Waltham, MA 02451